Doptelet
News/ News/ Sales and Marketing
Sobi stays on its acquisitive streak with $915m Dova deal
Phil Taylor
Doptelet, Dova Pharmaceuticals, Haematology, M&A, SOBI, thrombocytopenia
0 Comment
X
Sobi stays on its acquisitive streak with $915m Dova deal
https://pharmaphorum.com/news/sobi-stays-on-its-acquisitive-streak-with-915m-dova-deal/